Developments, news and strategies for drug development specific to phase I through Phase III global clinical trial management, execution, project management and outsourcing. Go→
News, articles and issues specific to clinical trial practice and implementation at the investigative site level. Go→
News, developments and strategies related to eClinical, data management, data collection, ePRO, and more information technology used in the drug development chain. Go→
News, articles and issues specific to laboratories role in the clinical trial, including ECG, imaging, genotyping, tissue samples and more. Go→
News, developments and strategies for clinical trials conduct in relation to the FDA, EMEA and other global regulatory authorities overseeing the drug development industry. Go→
News, articles and strategies related to clinical trial design which impact postmarketing studies, therapeutic areas, adaptive trials, statistics, protocols and more. Go→
|
|
ECPA Welcomes EFSA's Scientific Input but sees it as Late and Fears ED Rules will Crush Innovation in Farm Inputs
Publish date: Mar 20, 2013
![]()
PR Newswire BRUSSELS, March 20, 2013
BRUSSELS, March 20, 2013 /PRNewswire/ -- Today the European Food Safety Authority's (EFSA) Scientific Committee published its opinion on identifying endocrine disrupting
chemicals (EDs). ECPA welcomed the EFSA opinion but is concerned how late the input has been requested in a process
that has been rushed to meet political deadlines. The process to create new EU rules to identify and regulate EDs, threatens
to take action based on theoretical rather than proven risks, to the detriment of European industry competitiveness
and the broader public good.
"
ECPA appreciates EFSA
'
s
scientific input but sees its contribution as unfortunately late when the ED criteria are all but
finalised
. It is even more perplexing why the Commission
'
s own scientific committees have been absent from the d
evelopment of the ED criteria
" - said Friedhelm Schmider, Director General of European Crop Protection Association
(ECPA). "Endocrine disruption is a complex scientific issue and the Commission
'
s own scientific committees could have made an invaluable contribution in providing clear expert advice to European regulators
and politicians
"
. Ignoring established scientific principles and rushing the development of the ED criteria risks dealing a crushing blow
to European industrial innovation. The criteria as recently drafted would deny EU farmers access to essential and innovative
plant protection products which they safely use today. This will deprive EU farmers of important tools at a time when productivity
must rise to meet increasing demand for food. ECPA is clear that protecting human and environmental safety should not be compromised. Satisfying this goal and retaining
industry competiveness can co-exist if the ED criteria focus on actual rather than perceived risks. The EFSA opinion raises
several important technical considerations which ECPA welcomed and which demand further consideration in this respect: Further input of EFSA's Scientific Committee on the many complex topics around endocrine disruption is essential.
As the scientific debate continues on these topics, robust and independent scientific advice is important to ensure European
regulation addresses substantiated concerns rather than fear. A broader return to risk assessment over hazard assessment would
meaningfully contribute towards this goal. For the online version please follow the link: http://www.ecpa.eu/news-item/human-health/03-20-2013/716/ecpa-welcomes-efsa-s-scientific-input-sees-it-late-and-fears-e
Notes to editor (1). ECPA (European Crop Protection Association) represents the European R&D based manufacturers of plant protection
products (pesticides). Plant protection products are essential tools to help EU farmers protect their crops from pests
and diseases. (2). Under the new pesticides regulation, Regulation 1107/2009, substances considered to have "endocrine disrupting properties"
in humans or non-target species will not be approved. The inclusion of this hazard based criteria is a departure from
the established tool of risk assessment for evaluating the safety of substances, where both the hazard and exposure to a substance
is considered. No criteria are included to define what are considered to be endocrine disrupting properties, however,
the European Commission must come forward with a proposal for these criteria for pesticides by 13 December
2013. (3). Within the Commission, the responsibility for preparing the scientific criteria has been delegated to DG Environment,
who has been tasked with developing criteria for the identification of endocrine disruptors which will be applied to general
chemicals (REACH), biocides (Regulation 528/2012) as well as to pesticides (Regulation 1107/2009), and possibly also to cosmetics
(Regulation 1223/2009). (4). In February 2013, DG Environment released a revised proposal for the criteria for the
identification of endocrine disruptors, "
Revised version of possible elements for criteria for identification of endocrine disrupters
"
. The final horizontal criteria are expected to be published in May 2013 after
which they will be transposed into the different pieces of sectorial legislation, including Regulation 1107/2009 for pesticides. (5). In September 2012, DG Sanco requested a scientific opinion from the EFSA Scientific
Committee (European Food Safety Authority) as part of the input into the process for the development of the endocrine disruption
criteria. (6) The European Commission has three non-food related Scientific Committees, these include: Scientific Committee
on Consumer Safety (SCCS), Scientific Committee on Health and Environmental Risks (SCHER), Scientific Committee on Emerging
and Newly Identified Health Risks (SCENIHR). Although these committees have the relevant expertise none have been formally
consulted during the process for the development of the criteria for the identification of endocrine disruptors. (7) Experts from industry, including ECPA, have contributed significant scientific expertise to the issue of endocrine
disruption. Through ECETOC (European Centre for Ecotoxicology and Toxicology of Chemicals, industry experts developed
a regulatory proposal for managing endocrine disruptors (Bars, R., I. Fegert, M. Gross, D. Lewis, L. Weltje, A. Weyers, J.R. Wheeler, Galay-Burgos, M. 2012. Risk assessment of endocrine active chemicals:
identifying chemicals of regulatory concern. Regul Toxicol Pharmacol. 64(1):143-154). The publication
was recently awarded the title of "Best Published Paper Advancing the Science of Risk Assessment" by the Society of Toxicology. The European Crop Protection Association (ECPA) represents the crop protection industry interests at European level. Its
members include all major companies and national associations across Europe. For more general information:
http://www.ecpa.eu - http://www.pesticideinformation.eu - facebook.com/cropprotection -
twitter.com/cropprotection SOURCE The European Crop Protection Association (ECPA)
|
|